Moderna, Inc. (MRNA)
USD 25.23
(-1.95%)
USD 25.23
(-1.95%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 18.42 Billion USD | -28.74% |
| 2022 | 25.85 Billion USD | 4.82% |
| 2021 | 24.66 Billion USD | 236.24% |
| 2020 | 7.33 Billion USD | 361.6% |
| 2019 | 1.58 Billion USD | -19.0% |
| 2018 | 1.96 Billion USD | 80.93% |
| 2017 | 1.08 Billion USD | -23.47% |
| 2016 | 1.41 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 15.68 Billion USD | -6.27% |
| 2024 Q1 | 16.72 Billion USD | -9.21% |
| 2023 Q1 | 24.12 Billion USD | -6.7% |
| 2023 FY | 18.42 Billion USD | -28.74% |
| 2023 Q4 | 18.42 Billion USD | -5.26% |
| 2023 Q3 | 19.45 Billion USD | -11.12% |
| 2023 Q2 | 21.88 Billion USD | -9.29% |
| 2022 Q1 | 27.6 Billion USD | 11.92% |
| 2022 FY | 25.85 Billion USD | 4.82% |
| 2022 Q4 | 25.85 Billion USD | -0.76% |
| 2022 Q3 | 26.05 Billion USD | 0.05% |
| 2022 Q2 | 26.04 Billion USD | -5.67% |
| 2021 Q3 | 20.92 Billion USD | 29.53% |
| 2021 Q4 | 24.66 Billion USD | 17.9% |
| 2021 FY | 24.66 Billion USD | 236.24% |
| 2021 Q1 | 12.69 Billion USD | 73.02% |
| 2021 Q2 | 16.15 Billion USD | 27.25% |
| 2020 Q3 | 4.65 Billion USD | 33.42% |
| 2020 FY | 7.33 Billion USD | 361.6% |
| 2020 Q2 | 3.48 Billion USD | 68.61% |
| 2020 Q1 | 2.06 Billion USD | 30.08% |
| 2020 Q4 | 7.33 Billion USD | 57.75% |
| 2019 FY | 1.58 Billion USD | -19.0% |
| 2019 Q4 | 1.58 Billion USD | -0.09% |
| 2019 Q3 | 1.59 Billion USD | -5.6% |
| 2019 Q2 | 1.68 Billion USD | -6.7% |
| 2019 Q1 | 1.8 Billion USD | -7.95% |
| 2018 Q4 | 1.96 Billion USD | 31.76% |
| 2018 FY | 1.96 Billion USD | 80.93% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q2 | 1.6 Billion USD | 0.0% |
| 2018 Q3 | 1.48 Billion USD | -7.03% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 1.08 Billion USD | 0.0% |
| 2017 FY | 1.08 Billion USD | -23.47% |
| 2016 FY | 1.41 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -1138.228% |
| Alkermes plc | 2.13 Billion USD | -762.55% |
| Agenus Inc. | 313.91 Million USD | -5769.779% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -381.112% |
| Aptorum Group Limited | 20.64 Million USD | -89172.862% |
| Ardelyx, Inc. | 297.57 Million USD | -6091.969% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -2306.891% |
| Bicycle Therapeutics plc | 595.34 Million USD | -2995.017% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -24900.678% |
| ChromaDex Corporation | 54.96 Million USD | -33423.761% |
| Chimerix, Inc. | 212.77 Million USD | -8559.893% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -65073.118% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -4078.534% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -726.437% |
| Precision BioSciences, Inc. | 159.78 Million USD | -11432.034% |
| Dyadic International, Inc. | 8.21 Million USD | -224081.42% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -57952.93% |
| Fortress Biotech, Inc. | 167.52 Million USD | -10898.89% |
| Lantern Pharma Inc. | 43.64 Million USD | -42115.364% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -11320.815% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -126917.635% |
| Incyte Corporation | 6.78 Billion USD | -171.685% |
| IO Biotech, Inc. | 150.71 Million USD | -12125.481% |
| Jaguar Health, Inc. | 50.76 Million USD | -36198.091% |
| Novavax, Inc. | 1.85 Billion USD | -893.132% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -4743.759% |
| Opthea Limited | 188.79 Million USD | -9659.988% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -2111.835% |
| ContextLogic Inc. | 423 Million USD | -4256.028% |
| MiMedx Group, Inc. | 239.04 Million USD | -7608.108% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -10506.357% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -356322.934% |
| NextCure, Inc. | 129.41 Million USD | -14137.587% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -34055.112% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -50067.443% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -56944.674% |
| Vaxcyte, Inc. | 1.4 Billion USD | -1208.742% |
| PDS Biotechnology Corporation | 59.39 Million USD | -30925.383% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -2776.604% |
| Pharming Group N.V. | 462.85 Million USD | -3880.953% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -47537.022% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -2831.486% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -97270.093% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -97270.093% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -11045.657% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -40587.173% |
| Acelyrin, Inc. | 742.69 Million USD | -2380.981% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -279653.065% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -287671.357% |
| Summit Therapeutics Inc. | 202.94 Million USD | -8979.128% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -24674.787% |
| Senti Biosciences, Inc. | 119.48 Million USD | -15321.312% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -7969.475% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -10856.509% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -222894.07% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -385884.405% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -3827.177% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -14801.377% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -6601.606% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -3796.878% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -182245.374% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -8489.97% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -1627409.917% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -4352.424% |
| Immix Biopharma, Inc. | 19.92 Million USD | -92376.045% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -4879.664% |
| MEI Pharma, Inc. | 41.37 Million USD | -44434.139% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -56759.841% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -5306.722% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -15618.49% |
| Fortress Biotech, Inc. | 167.52 Million USD | -10898.89% |
| Precigen, Inc. | 151.04 Million USD | -12099.175% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -54065.442% |
| AlloVir, Inc. | 190.79 Million USD | -9557.435% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -4794.661% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -3539.941% |
| ImmuCell Corporation | 43.8 Million USD | -41960.713% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -2737.755% |
| Onconetix, Inc. | 88.82 Million USD | -20644.989% |
| PureTech Health plc | 693.97 Million USD | -2555.147% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -18762.671% |
| Elevation Oncology, Inc. | 89.09 Million USD | -20582.224% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -296997.71% |
| Seer, Inc. | 436.26 Million USD | -4123.541% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -22481.713% |
| Innoviva, Inc. | 1.24 Billion USD | -1381.777% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -13814.501% |
| ESSA Pharma Inc. | 149.12 Million USD | -12256.315% |
| GlycoMimetics, Inc. | 45.31 Million USD | -40560.709% |
| GT Biopharma, Inc. | 14.1 Million USD | -130497.491% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -5884.547% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -7523.406% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -3804.583% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -36245.346% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -19252.603% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -2917308.184% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -3153.517% |
| Aptose Biosciences Inc. | 12.92 Million USD | -142488.023% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -83221.712% |
| Soligenix, Inc. | 9.79 Million USD | -187971.725% |
| Century Therapeutics, Inc. | 360.69 Million USD | -5008.528% |
| Kura Oncology, Inc. | 448.93 Million USD | -4004.38% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -6670.556% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -106439.462% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -16513.272% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -8881.677% |
| Autolus Therapeutics plc | 375.38 Million USD | -4808.613% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -7222.482% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -5087.734% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -37403.053% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -2687.03% |
| GRI Bio, Inc. | 2.95 Million USD | -623242.355% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -173644.529% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -10706.087% |
| IGM Biosciences, Inc. | 423.41 Million USD | -4251.8% |
| INmune Bio, Inc. | 57 Million USD | -32225.749% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -8181.125% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -21851.066% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -70452.132% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -267595.452% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -24394.191% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -12412.733% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -11033.266% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -2826.601% |
| Verastem, Inc. | 149.71 Million USD | -12207.137% |
| Abeona Therapeutics Inc. | 64 Million USD | -28689.725% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -3497.746% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -11829.534% |
| Histogen Inc. | 19.07 Million USD | -96507.77% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -81250.368% |
| Surrozen, Inc. | 46.08 Million USD | -39886.979% |
| Organovo Holdings, Inc. | 6.34 Million USD | -290118.932% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -427554.33% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -12693.454% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -156026.08% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -24380.523% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -216186.645% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -4976.467% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -101732.628% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -4191.084% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -146002.197% |
| Apollomics, Inc. | 55.38 Million USD | -33167.734% |
| Amarin Corporation plc | 831.68 Million USD | -2115.505% |
| Mesoblast Limited | 669.15 Million USD | -2653.63% |
| Turnstone Biologics Corp. | 112.81 Million USD | -16232.934% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -3100.297% |
| Synaptogenix, Inc. | 31.11 Million USD | -59121.563% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -151131.123% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -3262.028% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -313680.331% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -250759.103% |
| Exelixis, Inc. | 2.94 Billion USD | -526.233% |
| Better Therapeutics, Inc. | 22.94 Million USD | -80212.078% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -4954.603% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -2236.161% |
| NLS Pharmaceutics AG | 1.84 Million USD | -997711.702% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -230841.788% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -125289.588% |
| Gritstone bio, Inc. | 177.76 Million USD | -10265.137% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -19218.515% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -103055.982% |
| Avid Bioservices, Inc. | 336.55 Million USD | -5374.853% |
| Insmed Incorporated | 1.32 Billion USD | -1285.583% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -191272.453% |
| MediWound Ltd. | 66.45 Million USD | -27625.365% |
| OmniAb, Inc. | 401.98 Million USD | -4483.753% |
| Alector, Inc. | 621.82 Million USD | -2863.204% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -5038.316% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -342518.074% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -32401.94% |
| Zai Lab Limited | 1.03 Billion USD | -1678.065% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -3751.154% |
| Aura Biosciences, Inc. | 255.07 Million USD | -7123.758% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -2356.705% |
| Immunic, Inc. | 54.29 Million USD | -33834.327% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -6821.239% |
| Veracyte, Inc. | 1.13 Billion USD | -1519.411% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -155751.643% |
| FibroGen, Inc. | 423.52 Million USD | -4250.588% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -524408.967% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -388912.806% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -339269.641% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | -61.726% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -209167.462% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -3460.896% |
| TG Therapeutics, Inc. | 329.58 Million USD | -5490.633% |
| Galecto, Inc. | 38.22 Million USD | -48101.533% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -64155.824% |
| Fortrea Holdings Inc. | 4.35 Billion USD | -322.886% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -7727.395% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -74072.772% |
| XBiotech Inc. | 227.24 Million USD | -8008.501% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -19218.515% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -12821.459% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -6344.55% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -14310.06% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -4723.573% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -1135.804% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -4950.405% |
| Vaxxinity, Inc. | 44.35 Million USD | -41443.977% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -3464.299% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -98914.844% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -5940.321% |
| NexImmune, Inc. | 8.59 Million USD | -214306.671% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -171861.486% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -107482.06% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 44.299% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -83083.112% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -4697234.71% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -10530.65% |
| Ainos, Inc. | 31.84 Million USD | -57767.324% |
| Pluri Inc. | 39.52 Million USD | -46516.237% |
| Prothena Corporation plc | 696.38 Million USD | -2545.962% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -6419.801% |
| Celularity Inc. | 143.88 Million USD | -12705.704% |
| Rallybio Corporation | 115.62 Million USD | -15836.689% |
| Cue Biopharma, Inc. | 61.53 Million USD | -29846.368% |
| MeiraGTx Holdings plc | 458.16 Million USD | -3921.669% |
| Omeros Corporation | 378.26 Million USD | -4771.137% |
| Humacyte, Inc. | 128.22 Million USD | -14270.277% |
| Immunocore Holdings plc | 597 Million USD | -2986.427% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -58846.223% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -26787.495% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -1656.112% |
| CalciMedica, Inc. | 12.18 Million USD | -151118.712% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -7164.341% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -10681.239% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -5824.092% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -3159.514% |
| Pulmatrix, Inc. | 33.95 Million USD | -54161.146% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -67777.404% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -12981.259% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -1316.32% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -14053.267% |
| Cytokinetics, Incorporated | 824.31 Million USD | -2135.308% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -87131.927% |
| Nutriband Inc. | 7.51 Million USD | -245019.363% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -23237.64% |
| Vor Biopharma Inc. | 209.82 Million USD | -8681.478% |
| Roivant Sciences Ltd. | 7.22 Billion USD | -155.12% |
| Evogene Ltd. | 51.1 Million USD | -35958.003% |
| ProKidney Corp. | 420.55 Million USD | -4281.384% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -33503.852% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -193444.768% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -3272.378% |
| CorMedix Inc. | 82.05 Million USD | -22354.313% |
| BioLineRx Ltd. | 63.92 Million USD | -28724.404% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -4477.126% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -65240.426% |
| Atai Life Sciences N.V. | 293.47 Million USD | -6178.494% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -11195.324% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -14361.065% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -3178.49% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -18951.065% |
| MediciNova, Inc. | 66.26 Million USD | -27704.446% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -20851.017% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -412820.055% |
| GeoVax Labs, Inc. | 9.28 Million USD | -198387.184% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -3032.416% |
| Biomea Fusion, Inc. | 199.92 Million USD | -9116.364% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -868.169% |
| Mereo BioPharma Group plc | 66.49 Million USD | -27608.687% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -3698.423% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -2906.461% |
| Absci Corporation | 234.48 Million USD | -7758.24% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -251793.37% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -5321.15% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -11061.726% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -3400.899% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -6535.385% |
| Allakos Inc. | 243.61 Million USD | -7463.729% |
| Imunon, Inc. | 21.91 Million USD | -83967.625% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -7050.341% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -2864.682% |
| BioAtla, Inc. | 119.65 Million USD | -15298.887% |
| NLS Pharmaceutics AG | 1.84 Million USD | -997711.702% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -572136.025% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -2766.356% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -19106.755% |
| XOMA Corporation | 234.3 Million USD | -7764.243% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -8228.7% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -14541.938% |
| aTyr Pharma, Inc. | 122.06 Million USD | -14994.989% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -11872.476% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -3075.413% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -3657.157% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -16579.793% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -121463.109% |
| Akari Therapeutics, Plc | 4.35 Million USD | -422999.885% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -108050.73% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -963.077% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -597373.529% |
| UroGen Pharma Ltd. | 178.31 Million USD | -10233.631% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -3814.296% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -3315628.386% |
| Orgenesis Inc. | 14.55 Million USD | -126521.77% |
| Entera Bio Ltd. | 11.76 Million USD | -156517.085% |
| GH Research PLC | 226.3 Million USD | -8042.289% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -33589.253% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -17050.676% |
| Xencor, Inc. | 952.69 Million USD | -1834.098% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -236623.305% |
| Replimune Group, Inc. | 487.72 Million USD | -3677.972% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -228196.33% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -2741.589% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -597373.529% |
| Portage Biotech Inc. | 7.77 Million USD | -236768.492% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -412820.055% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -6553.307% |
| OncoCyte Corporation | 74.89 Million USD | -24503.429% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -906134.753% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -318322.961% |
| Purple Biotech Ltd. | 44.3 Million USD | -41491.802% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -53894.022% |
| scPharmaceuticals Inc. | 94.47 Million USD | -19402.747% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -102011.626% |
| HilleVax, Inc. | 344.43 Million USD | -5249.646% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -580063.728% |
| Tharimmune, Inc. | 10.94 Million USD | -168229.421% |
| Genprex, Inc. | 10.67 Million USD | -172580.204% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -3613.459% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -19043.498% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -759421.847% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -442254.123% |
| OKYO Pharma Limited | 1.54 Million USD | -1195412.255% |
| Savara Inc. | 177.56 Million USD | -10277.103% |
| Curis, Inc. | 77.28 Million USD | -23742.551% |
| Daré Bioscience, Inc. | 21.28 Million USD | -86479.334% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -28713.675% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -227775.34% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -95021.573% |
| BeiGene, Ltd. | 5.8 Billion USD | -217.401% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -151317.536% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -782.222% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -5047.632% |
| Erasca, Inc. | 395.29 Million USD | -4561.305% |
| bluebird bio, Inc. | 619.16 Million USD | -2875.963% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -426095.405% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | -169.323% |
| DBV Technologies S.A. | 182.98 Million USD | -9969.623% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -426095.405% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -101047.28% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -158936.769% |
| Molecular Templates, Inc. | 35.38 Million USD | -51975.856% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -13226.583% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -2235.619% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -5966.073% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -17626.512% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -3857.245% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -5778.693% |
| MacroGenics, Inc. | 306.82 Million USD | -5905.476% |
| RenovoRx, Inc. | 1.46 Million USD | -1256789.495% |
| Adicet Bio, Inc. | 207.29 Million USD | -8788.782% |
| Prime Medicine, Inc. | 193.85 Million USD | -9405.239% |
| Aditxt, Inc. | 44.57 Million USD | -41233.987% |
| Adagene Inc. | 115.72 Million USD | -15821.701% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -413578.001% |
| Quantum-Si incorporated | 298.25 Million USD | -6078.039% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -1138.764% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -238915.514% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -5145.373% |
| SciSparc Ltd. | 11.18 Million USD | -164682.686% |
| Vericel Corporation | 353.65 Million USD | -5110.133% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -150776.852% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -32282.78% |
| Generation Bio Co. | 374.75 Million USD | -4816.773% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -7135.359% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -11520.325% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -5297.741% |
| Invivyd, Inc. | 229.18 Million USD | -7939.934% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -2083.227% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -151313.791% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -10002.528% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -90117.391% |
| 2seventy bio, Inc. | 565.42 Million USD | -3158.782% |
| ADMA Biologics, Inc. | 329.18 Million USD | -5497.511% |
| Clene Inc. | 52.34 Million USD | -35103.76% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -31271.773% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -14085.413% |
| GeoVax Labs, Inc. | 9.28 Million USD | -198387.184% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -2718.728% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -17683.8% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -14031.885% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -18788.38% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -25853.209% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -7496.69% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -840.059% |
| Evaxion Biotech A/S | 12.88 Million USD | -142863.338% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -7210.164% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -2348.026% |
| Trevena, Inc. | 40.6 Million USD | -45278.648% |
| Surrozen, Inc. | 46.08 Million USD | -39886.979% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -8058.259% |
| Cingulate Inc. | 3.49 Million USD | -527648.468% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -110706.423% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -27949.931% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -157594.379% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -6762.135% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -2360.225% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -14536.355% |
| Clearmind Medicine Inc. | 4.32 Million USD | -425994.877% |
| Kronos Bio, Inc. | 213.27 Million USD | -8539.388% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -11431.818% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -215141.671% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -4900.407% |
| Statera Biopharma, Inc. | 21.16 Million USD | -86939.557% |
| ImmunityBio, Inc. | 504.45 Million USD | -3552.677% |
| Korro Bio, Inc. | 221.66 Million USD | -8212.619% |
| Kineta, Inc. | 10.28 Million USD | -179123.811% |
| BioVie Inc. | 25.2 Million USD | -72994.842% |
| Codexis, Inc. | 136.56 Million USD | -13392.871% |
| Celularity Inc. | 143.88 Million USD | -12705.704% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -2800.12% |
| Celcuity Inc. | 191.21 Million USD | -9536.052% |
| Virax Biolabs Group Limited | 5.48 Million USD | -335897.523% |
| Cibus, Inc. | 544.41 Million USD | -3284.575% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -14536.122% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -89590.421% |
| IN8bio, Inc. | 33.7 Million USD | -54561.96% |
| Kodiak Sciences Inc. | 479.37 Million USD | -3743.779% |
| Annexon, Inc. | 297.67 Million USD | -6089.993% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -10550.251% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -13303.749% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -87672.115% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -516.239% |
| Eyenovia, Inc. | 28.77 Million USD | -63925.02% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -7892.955% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -254966.445% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -30143.246% |
| Arcellx, Inc. | 825.13 Million USD | -2133.097% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -22470.648% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -3885.939% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -59821.951% |
| Moolec Science SA | 24.05 Million USD | -76511.279% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -5841.475% |
| Geron Corporation | 394.07 Million USD | -4575.748% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -18016.213% |
| Royalty Pharma plc | 16.38 Billion USD | -12.478% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -2996.973% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -263323.693% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -153101.263% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -8050.933% |
| Humacyte, Inc. | 128.22 Million USD | -14270.277% |
| Structure Therapeutics Inc. | 482.01 Million USD | -3722.686% |
| 89bio, Inc. | 596.26 Million USD | -2990.216% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -7207.497% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -995900.0% |
| Genelux Corporation | 27.89 Million USD | -65959.585% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -20510.047% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -7931.243% |
| Notable Labs, Ltd. | 19.54 Million USD | -94194.048% |
| Liquidia Corporation | 120.43 Million USD | -15200.047% |
| Mustang Bio, Inc. | 17.74 Million USD | -103755.259% |
| Immunovant, Inc. | 666.71 Million USD | -2663.712% |
| Quantum-Si incorporated | 298.25 Million USD | -6078.039% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -12660.299% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -33921.418% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -10396.394% |
| Acasti Pharma Inc. | 73.3 Million USD | -25037.79% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -404664.117% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -70452.132% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -1809.83% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -354934.511% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -80783.192% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -35607.226% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -10097.52% |
| PepGen Inc. | 143.05 Million USD | -12780.631% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -48114.146% |
| United Therapeutics Corporation | 7.16 Billion USD | -157.095% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -95943.784% |
| Solid Biosciences Inc. | 164.93 Million USD | -11071.403% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -313680.331% |
| Immuneering Corporation | 102.58 Million USD | -17861.771% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -427554.33% |
| Silo Pharma, Inc. | 7.74 Million USD | -237773.284% |
| Belite Bio, Inc | 94.64 Million USD | -19369.157% |
| XOMA Corporation | 234.3 Million USD | -7764.243% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -7801.779% |
| Bionomics Limited | 27.64 Million USD | -66542.331% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -4490.388% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -17058.342% |
| uniQure N.V. | 831.68 Million USD | -2115.492% |
| Cassava Sciences, Inc. | 151.66 Million USD | -12049.305% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -413578.001% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -6627.641% |
| Forte Biosciences, Inc. | 38.98 Million USD | -47170.395% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -452281.151% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -49928.509% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -254966.445% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -524408.967% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -155775.137% |
| Altimmune, Inc. | 210.64 Million USD | -8647.626% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -2268.746% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -17058.342% |
| Compugen Ltd. | 121.33 Million USD | -15086.18% |
| Peak Bio, Inc. | 2.59 Million USD | -709570.835% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -10592.463% |
| Benitec Biopharma Inc. | 52.21 Million USD | -35192.09% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -5289.941% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -52889.388% |
| Zura Bio Limited | 100.84 Million USD | -18171.967% |
| PolyPid Ltd. | 15.37 Million USD | -119767.291% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -15346.909% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -52889.388% |
| Instil Bio, Inc. | 325.63 Million USD | -5558.57% |
| argenx SE | 4.54 Billion USD | -305.639% |
| Immunome, Inc. | 148.54 Million USD | -12304.739% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -11645.657% |
| Verona Pharma plc | 308.12 Million USD | -5880.06% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -21089.296% |
| Shattuck Labs, Inc. | 159.56 Million USD | -11447.718% |
| CervoMed Inc. | 9.97 Million USD | -184667.723% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -9677.349% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -161701.897% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -10170.617% |
| Moolec Science SA | 24.05 Million USD | -76511.279% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -301102.456% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -10554.29% |
| AnaptysBio, Inc. | 452.38 Million USD | -3973.043% |
| Design Therapeutics, Inc. | 289.64 Million USD | -6261.624% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -25201.751% |
| NeurAxis, Inc. | 509.49 Thousand USD | -3616400.948% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -339988.594% |
| Lumos Pharma, Inc. | 40.63 Million USD | -45241.798% |
| Achilles Therapeutics plc | 161.45 Million USD | -11312.397% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -21089.296% |
| 180 Life Sciences Corp. | 5.25 Million USD | -350239.083% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -26062.965% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -215141.671% |
| Nutriband Inc. | 7.51 Million USD | -245019.363% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -7134.791% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -9145.312% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -24077.295% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -31715.042% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -3399.448% |
| Palisade Bio, Inc. | 14.05 Million USD | -131027.242% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -8661.977% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -1162.302% |
| Neurogene Inc. | 222.57 Million USD | -8178.632% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -2749.583% |
| AEON Biopharma, Inc. | 6.84 Million USD | -269089.189% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -3967.226% |
| Sesen Bio, Inc. | 189.17 Million USD | -9640.239% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -6677.579% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -134279.92% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -2261.245% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -6801.279% |
| Athira Pharma, Inc. | 160.24 Million USD | -11398.643% |
| Vaccinex, Inc. | 3.63 Million USD | -507363.509% |
| HCW Biologics Inc. | 28.51 Million USD | -64521.659% |
| XOMA Corporation | 234.3 Million USD | -7764.243% |
| Nektar Therapeutics | 398.03 Million USD | -4529.264% |
| Arvinas, Inc. | 1.3 Billion USD | -1312.387% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -108050.73% |
| Merus N.V. | 458.49 Million USD | -3918.809% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -8916.177% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -10125.078% |
| Rezolute, Inc. | 132.73 Million USD | -13781.585% |
| Clene Inc. | 52.34 Million USD | -35103.76% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -123366.568% |
| BeyondSpring Inc. | 24.8 Million USD | -74174.428% |
| Synlogic, Inc. | 75.55 Million USD | -24289.146% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -155236.368% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -196674.883% |
| Peak Bio, Inc. | 2.59 Million USD | -709570.835% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -10439.2% |
| Krystal Biotech, Inc. | 818.35 Million USD | -2151.59% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -7563.514% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -2438.758% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -514999.349% |
| MannKind Corporation | 475.19 Million USD | -3777.542% |
| Ikena Oncology, Inc. | 192.09 Million USD | -9492.279% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -137674.787% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -15711.016% |
| Gossamer Bio, Inc. | 311.91 Million USD | -5807.36% |
| CohBar, Inc. | 16.36 Million USD | -112489.362% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -52301.672% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -251793.37% |
| Legend Biotech Corporation | 1.84 Billion USD | -896.749% |
| Mural Oncology plc | 301.74 Million USD | -6006.481% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -58929.313% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -324278.279% |
| Disc Medicine, Inc. | 367.99 Million USD | -4907.12% |
| Champions Oncology, Inc. | 26.13 Million USD | -70411.251% |
| REGENXBIO Inc. | 573.97 Million USD | -3110.272% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -680307.003% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -11835.02% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -152488.944% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -5318.854% |
| Vaxart, Inc. | 91.83 Million USD | -19965.338% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -30659.275% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -12322.56% |
| Cellectis S.A. | 334.27 Million USD | -5412.31% |
| Longeveron Inc. | 12.17 Million USD | -151205.633% |
| Repare Therapeutics Inc. | 253.9 Million USD | -7157.159% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -464.422% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -9074.147% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -782.222% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -1133807.692% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -6534.955% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -11197.502% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -13180.574% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -72096.536% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 18.936% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -1496.822% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -150776.852% |
| Veru Inc. | 50.59 Million USD | -36317.953% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -40349.586% |
| Cingulate Inc. | 3.49 Million USD | -527648.468% |
| Passage Bio, Inc. | 150.54 Million USD | -12139.53% |
| Context Therapeutics Inc. | 16.06 Million USD | -114612.719% |
| Exicure, Inc. | 11.58 Million USD | -159019.171% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -4799.906% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -11299.265% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -105360.165% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -5437.574% |
| Nuvalent, Inc. | 732.38 Million USD | -2415.893% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -123199.669% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -20475.295% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -129742.858% |
| OmniAb, Inc. | 401.98 Million USD | -4483.753% |
| Anew Medical, Inc. | 19.45 Million USD | -94606.232% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -68842.668% |
| Lipocine Inc. | 23 Million USD | -80009.31% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -13079.598% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -5930.141% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -21851.066% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -15060.441% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -232111.72% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -1988.46% |
| Ocugen, Inc. | 64.54 Million USD | -28446.64% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -14695.128% |
| Q32 Bio Inc. | 306.11 Million USD | -5919.228% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -437780.228% |
| Alumis Inc. Common Stock | 89.61 Million USD | -20461.978% |
| Equillium, Inc. | 50.53 Million USD | -36365.466% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -24404.289% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -44543.632% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -1083238.772% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -70386.974% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -28493.597% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -494277.283% |
| Dominari Holdings Inc. | 57.55 Million USD | -31912.926% |
| Edesa Biotech, Inc. | 8.89 Million USD | -207156.404% |
| vTv Therapeutics Inc. | 11.01 Million USD | -167135.433% |
| Bio-Techne Corporation | 2.81 Billion USD | -554.986% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -1866.241% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -2170.755% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -6536.054% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -44084.931% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -2660.086% |
| Nkarta, Inc. | 378.88 Million USD | -4763.217% |
| BioCardia, Inc. | 2.98 Million USD | -616773.117% |
| Iterum Therapeutics plc | 26.25 Million USD | -70070.227% |